Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $767.18 billion, total revenue of $170.65 billion and a weighted average PE ratio of 42.83.
Market Cap
767.18B
Revenue
170.65B
Profits
17.91B
PE Ratio
42.83
Profit Margin
10.50%
Dividend Yield
0.21%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 207.93B | -1.54% | 1,962,048 | 46.34B |
| 2 | DHR | Danaher Corporation | 138.14B | 2.61% | 5,340,633 | 25.11B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 43.87B | 2.18% | 512,647 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 38.94B | -0.49% | 1,830,516 | 7.23B |
| 5 | NTRA | Natera, Inc. | 36.95B | -1.51% | 977,943 | 2.50B |
| 6 | WAT | Waters Corporation | 36.45B | -0.93% | 803,760 | 3.77B |
| 7 | IQV | IQVIA Holdings Inc. | 35.59B | 2.48% | 2,160,161 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 28.67B | -2.38% | 1,738,895 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 27.00B | 0.69% | 110,398 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.59B | 1.75% | 1,143,249 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 24.70B | 1.48% | 655,435 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 19.29B | -1.26% | 1,292,966 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.45B | -2.00% | 415,466 | 2.78B |
| 14 | ICLR | ICON Public Limited Company | 12.93B | 1.82% | 778,242 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.06B | -2.17% | 1,349,053 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 10.80B | -1.01% | 720,345 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.50B | -0.70% | 1,651,529 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 5.89B | 1.51% | 480,074 | 354.54M |
| 19 | TWST | Twist Bioscience Corporation | 5.39B | -4.13% | 1,347,517 | 409.48M |
| 20 | SHC | Sotera Health Company | 4.92B | -0.63% | 2,344,471 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.84B | -0.10% | 476,742 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 4.44B | -1.77% | 748,902 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.61B | 1.21% | 2,437,488 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.87B | -1.58% | 441,439 | 156.12M |
| 25 | CDNA | CareDx, Inc. | 1.88B | -2.10% | 604,619 | 412.82M |
| 26 | WGS | GeneDx Holdings Corp. | 1.80B | 2.44% | 611,524 | 442.68M |
| 27 | NEO | NeoGenomics, Inc. | 1.71B | -5.40% | 1,795,795 | 745.97M |
| 28 | FRNM | Freenome, Inc. | 1.28B | 1.25% | 1,449,225 | 34.24M |
| 29 | PSNL | Personalis, Inc. | 1.25B | 1.70% | 4,618,079 | 64.52M |
| 30 | OPK | OPKO Health, Inc. | 925.45M | 1.64% | 4,349,942 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 741.26M | -1.01% | 291,639 | 339.92M |
| 32 | FLGT | Fulgent Genetics, Inc. | 556.08M | -0.46% | 221,329 | 320.35M |
| 33 | MYGN | Myriad Genetics, Inc. | 514.74M | -2.85% | 1,172,183 | 829.00M |
| 34 | BDSX | Biodesix, Inc. | 230.11M | 1.00% | 75,474 | 96.10M |
| 35 | IMDX | Insight Molecular Diagnostics Inc. | 151.76M | -0.84% | 56,972 | 1.95M |
| 36 | XGN | Exagen Inc. | 106.30M | -5.98% | 201,762 | 68.38M |
| 37 | BNR | Burning Rock Biotech Limited | 99.14M | 5.03% | 457 | 74.58M |
| 38 | PRPO | Precipio, Inc. | 40.97M | -3.21% | 187,182 | 25.83M |
| 39 | QUCY | Quantum Cyber N.V. | 25.04M | 1.85% | 443,278 | 537.08K |
| 40 | ADVB | Advanced Biomed Inc. | 23.72M | -24.34% | 456,907 | - |
| 41 | MDXH | MDxHealth SA | 21.47M | 1.95% | 150,966 | 110.97M |
| 42 | XWEL | XWELL, Inc. | 8.95M | 0.95% | 16,379 | 28.83M |
| 43 | MBAI | Check-Cap Ltd. | 7.80M | -2.73% | 23,452 | - |
| 44 | NDRA | ENDRA Life Sciences Inc. | 6.07M | -1.65% | 5,946 | - |
| 45 | BIAF | bioAffinity Technologies, Inc. | 3.09M | 3.30% | 200,376 | 5.66M |
| 46 | ISPC | iSpecimen Inc. | 2.89M | 2.03% | 53,119 | 1.03M |